{"id":783792,"date":"2023-09-13T11:24:43","date_gmt":"2023-09-13T15:24:43","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\/"},"modified":"2023-09-13T11:24:43","modified_gmt":"2023-09-13T15:24:43","slug":"neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\/","title":{"rendered":"NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">CARMEL, Ind., Sept.  13, 2023  (GLOBE NEWSWIRE) &#8212; NeurAxis, Inc. (NYSE American: NRXS), (\u201cNeurAxis,\u201d or the \u201cCompany\u201d), a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children and adults, today announced that President and Chief Executive Officer Brian Carrico and Chief Medical Officer Dr. Adrian Miranda, will present at the upcoming Gilmartin Group Emerging Growth Showcase on Thursday, September 21, 2023, at 9:00 am ET.<\/p>\n<p align=\"justify\">To access the live webcast, please visit the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_-gExLY_Uplf-2E_-W7fUSDDsqfVKshRCVWIZllLSQhfENDbb6ZkVMIW98-1EtGzg6Fs0ze_wI3WEKTYjeeOig==\" rel=\"nofollow noopener\" target=\"_blank\">investors page<\/a> of the NeurAxis website. To ask a question, please feel free to send your questions ahead of time to <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RNDoeQObYxNKHDHoPT9keYr5UJA7UPGkVOmeh8uzJoZ42dijYHXSSV_tccE4E5i-v6s4gLYNgVl9ZOSK5Vox9A==\" rel=\"nofollow noopener\" target=\"_blank\">IR@neuraxis.com<\/a>. The webcast will be available for replay on NeurAxis\u2019 investor relations website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UObLUgKQTeWhWbUrE7p5FbcFvtQHfVve9moYAoRHlUe4Jmq9CIBUVZ8CAzIcHqx4HHQZcn63f3-ZeRh_SkKwaGg3Y25v2jJ1FQE90b5TpDM=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/ir.neuraxis.com\/<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About NeurAxis, Inc.<\/strong><br \/>\n        <br \/>NeurAxis, Inc., is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults. NeurAxis is dedicated to advancing science and leveraging evidence-based medicine to drive adoption of its IB-Stim\u2122 therapy, which is its proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology, by the medical, scientific, and patient communities. IB-Stim\u2122 is FDA cleared for functional abdominal pain associated with irritable bowel syndrome (IBS) in adolescents 11-18 years old. Additional clinical trials of PENFS in multiple pediatric and adult conditions with large unmet healthcare needs are underway. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=trEs85RSWC23JNpNVnQAT8hzMVQXKN2XdLNXFWimqaz6iyCX6F1YDjZu2vQGX9FWZiPg12mF_OtV6ChZAFTy2tSCoR4kjoSpfBUw6nWHk_BoHpqzLzUUh6iA7XLoazfuZSobFTcNZ74F3Ue6ZmdeaKKcklfPLtZdKIctpu1ufA57QbsD0FCSoYaAQZQEWq1GAayxFnOPUtjMJMKZ__zNCSwJoUSPvGRYyWdIrNBBpUc=\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/neuraxis.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Contacts:<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Company<\/strong><br \/>\n        <br \/>\n        <strong>NeurAxis, Inc.<\/strong><br \/>\n        <br \/>info@neuraxis.com<\/p>\n<p align=\"justify\">\n        <strong>Investor Relations<\/strong><br \/>\n        <br \/>\n        <strong>Gilmartin Group<\/strong><br \/>\n        <br \/>IR@neuraxis.com<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMTExMCM1ODExMzA4IzIyNTIyNDI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/OTc3MzIwM2QtMzlkMy00YmY3LWE5ZmYtYzAyM2Y5YzVkODE4LTEyNjM3OTU=\/tiny\/NeurAxis-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CARMEL, Ind., Sept. 13, 2023 (GLOBE NEWSWIRE) &#8212; NeurAxis, Inc. (NYSE American: NRXS), (\u201cNeurAxis,\u201d or the \u201cCompany\u201d), a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children and adults, today announced that President and Chief Executive Officer Brian Carrico and Chief Medical Officer Dr. Adrian Miranda, will present at the upcoming Gilmartin Group Emerging Growth Showcase on Thursday, September 21, 2023, at 9:00 am ET. To access the live webcast, please visit the investors page of the NeurAxis website. To ask a question, please feel free to send your questions ahead of time to IR@neuraxis.com. The webcast will be available for replay on NeurAxis\u2019 investor relations website at https:\/\/ir.neuraxis.com\/. About NeurAxis, Inc. NeurAxis, Inc., is &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-783792","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CARMEL, Ind., Sept. 13, 2023 (GLOBE NEWSWIRE) &#8212; NeurAxis, Inc. (NYSE American: NRXS), (\u201cNeurAxis,\u201d or the \u201cCompany\u201d), a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children and adults, today announced that President and Chief Executive Officer Brian Carrico and Chief Medical Officer Dr. Adrian Miranda, will present at the upcoming Gilmartin Group Emerging Growth Showcase on Thursday, September 21, 2023, at 9:00 am ET. To access the live webcast, please visit the investors page of the NeurAxis website. To ask a question, please feel free to send your questions ahead of time to IR@neuraxis.com. The webcast will be available for replay on NeurAxis\u2019 investor relations website at https:\/\/ir.neuraxis.com\/. About NeurAxis, Inc. NeurAxis, Inc., is &hellip; Continue reading &quot;NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-13T15:24:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMTExMCM1ODExMzA4IzIyNTIyNDI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase\",\"datePublished\":\"2023-09-13T15:24:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\\\/\"},\"wordCount\":242,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyMTExMCM1ODExMzA4IzIyNTIyNDI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\\\/\",\"name\":\"NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyMTExMCM1ODExMzA4IzIyNTIyNDI=\",\"datePublished\":\"2023-09-13T15:24:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyMTExMCM1ODExMzA4IzIyNTIyNDI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyMTExMCM1ODExMzA4IzIyNTIyNDI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\/","og_locale":"en_US","og_type":"article","og_title":"NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase - Market Newsdesk","og_description":"CARMEL, Ind., Sept. 13, 2023 (GLOBE NEWSWIRE) &#8212; NeurAxis, Inc. (NYSE American: NRXS), (\u201cNeurAxis,\u201d or the \u201cCompany\u201d), a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children and adults, today announced that President and Chief Executive Officer Brian Carrico and Chief Medical Officer Dr. Adrian Miranda, will present at the upcoming Gilmartin Group Emerging Growth Showcase on Thursday, September 21, 2023, at 9:00 am ET. To access the live webcast, please visit the investors page of the NeurAxis website. To ask a question, please feel free to send your questions ahead of time to IR@neuraxis.com. The webcast will be available for replay on NeurAxis\u2019 investor relations website at https:\/\/ir.neuraxis.com\/. About NeurAxis, Inc. NeurAxis, Inc., is &hellip; Continue reading \"NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-13T15:24:43+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMTExMCM1ODExMzA4IzIyNTIyNDI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase","datePublished":"2023-09-13T15:24:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\/"},"wordCount":242,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMTExMCM1ODExMzA4IzIyNTIyNDI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\/","name":"NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMTExMCM1ODExMzA4IzIyNTIyNDI=","datePublished":"2023-09-13T15:24:43+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMTExMCM1ODExMzA4IzIyNTIyNDI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMTExMCM1ODExMzA4IzIyNTIyNDI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/783792","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=783792"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/783792\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=783792"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=783792"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=783792"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}